CONSOLI, Agostino
 Distribuzione geografica
Continente #
NA - Nord America 6.379
EU - Europa 5.892
AS - Asia 2.556
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 17
SA - Sud America 15
OC - Oceania 4
Totale 14.886
Nazione #
US - Stati Uniti d'America 6.353
CN - Cina 1.351
UA - Ucraina 1.184
IE - Irlanda 1.117
TR - Turchia 913
SE - Svezia 754
IT - Italia 741
GB - Regno Unito 695
FR - Francia 664
DE - Germania 391
FI - Finlandia 229
IN - India 225
BE - Belgio 25
VN - Vietnam 23
CA - Canada 22
RU - Federazione Russa 19
EG - Egitto 17
EU - Europa 16
PL - Polonia 16
NL - Olanda 15
KR - Corea 11
IL - Israele 10
ES - Italia 9
RO - Romania 9
CZ - Repubblica Ceca 6
BR - Brasile 5
JP - Giappone 5
IR - Iran 4
PE - Perù 4
AR - Argentina 3
AT - Austria 3
AU - Australia 3
BD - Bangladesh 3
BG - Bulgaria 3
GR - Grecia 3
MY - Malesia 3
PK - Pakistan 3
DK - Danimarca 2
ET - Etiopia 2
HK - Hong Kong 2
MX - Messico 2
PT - Portogallo 2
SC - Seychelles 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
LI - Liechtenstein 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UG - Uganda 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 14.886
Città #
Jacksonville 1.362
Chandler 1.293
Dublin 1.112
Southend 560
Princeton 538
Izmir 502
Nanjing 385
Dearborn 379
Ashburn 264
Wilmington 256
Cambridge 222
Beijing 209
Ann Arbor 157
Nanchang 148
Altamura 140
Boardman 113
Shenyang 97
Woodbridge 96
Chieti 88
Hebei 68
Los Angeles 67
Kunming 65
Grevenbroich 61
Tianjin 59
Jiaxing 56
Norwalk 52
Washington 50
Changsha 33
New York 33
Ningbo 32
Rome 32
Hangzhou 30
Milan 28
Pescara 28
Falls Church 27
Orange 27
Houston 26
Dong Ket 23
Jinan 23
Brussels 21
Helsinki 19
San Mateo 19
Guangzhou 18
Hefei 17
Changchun 16
Leawood 16
Augusta 14
Cedar Knolls 14
Toronto 14
Auburn Hills 13
Lanzhou 13
Munich 13
Zhengzhou 13
Alexandria 11
Kocaeli 11
Seattle 11
Naples 10
Taizhou 10
Guardiagrele 9
Kraków 9
London 9
Palermo 9
Wŏnju 9
Florence 8
Simi Valley 8
Viterbo 8
San Vito Chietino 7
Shanghai 7
Tappahannock 7
Madrid 6
Bialystok 5
Chengdu 5
Düsseldorf 5
Fuzhou 5
Lissone 5
Mountain View 5
Mumbai 5
Ottawa 5
Perugia 5
Santa Clara 5
Trieste 5
Bari 4
Bellante 4
Brusciano 4
Città Di Castello 4
Dordrecht 4
Edinburgh 4
Frankfurt am Main 4
Genoa 4
Haikou 4
L'aquila 4
Lanciano 4
L’Aquila 4
Tokyo 4
Tortoreto 4
Wuhan 4
Alba Adriatica 3
Amsterdam 3
Andover 3
Badajoz 3
Totale 9.237
Nome #
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 118
Obesity modifies the effects of the Asp905Tyr variant of PPP1R3A on risk of type 2 diabetes and insulin sensitivity 113
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 110
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. 109
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 106
Principi di Endocrinologia 105
A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment 105
Centella Asiatica inhibits TNFα-induced adhesion molecule expression in endothelial cells of umbilical cords from gestational diabetic women. 103
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 99
Transmural distribution of antioxidant defences and lipid peroxidation in the rabbit left ventricular myocardium 97
Preliminari esperienze terapeutiche del diabete in gravidanza 96
Relationship between patient-practice oriented knowledge and metabolic control in intensively treated Type 1 diabetic patient: Result of the validation of the knowledge and Practices Diabetes Questionnaire 95
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 94
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 94
ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1678-83. 94
TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells. 93
Endocrinologia Clinica 93
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 92
Heightened free radical activity in angina pectoris 92
Necessity of an obese patients preselection before starting behavioral therapy 90
DHEA mimics acute actions of insulin to stimulate production of both NO and ET-1 via distinct PI 3-kinase- and MAP-kinase-dependent pathways in vascular endothelium. 90
Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation. 89
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 88
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture. 87
Valutazione del fabbisogno insulinico post-prandiale in pazienti diabetici trattati con microinfusore insulinico 87
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 87
Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus? 86
Insulin enhances vascular adhesion molecule (VCAM-1) expression in human cultured endothelial cells through a pro-atherogenic p38MAP-kinase mediated pathway. 85
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 84
Plasminogen Activator Inhibitor-1 synthesis is increased in arterial wall of diabetic subjects 83
Phenylmethimazole reverses plasminogen activator inhibitor-1 (PAI-1) overexpression in diabetic rats 83
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences 83
Variations in carbohydrate, lipid and protein oxidation evaluated by indirect calorimetry in obese subjects on a "single-meal" low-calorie diet. 82
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. 81
Treatment of brittle diabetes by continuous subcutaneous in-insulin infusion. Comparison with conventional treatment 81
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 81
[Type 2 diabetes treatment and cardiovascular risk: what can we learn from trials?] 81
I glitazoni 80
Iperespressione dell'inibitore dell'attivatore del plasminogeno di tipo 1 (PAI-1) nel fegato e nella aorta di ratti diabetici 79
Selective insulin resistance affecting nitric oxide release but nor plasminogen activator inhibitor-1 synthesis in fibroblast from insulin-resistant individuals. 79
La terapia insulinica: tradizione e novità 79
null 79
Policaptil Gel Retard® reduces body weight and improves insulin sensitivity in obese subjects 78
Distribuzione transmurale dei sistemi antiossidanti e della perossidazione lipidica nel ventricolo sinistro di coniglio 78
Synergic effect of glucose and insulin in stimulating plasminogen activator inhibitor 1 (PAI-1) expression and secretion in human vascular smooth cells (vSMC) 77
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 77
Transcriptome analysis of human primary endothelial cells (HUVEC) from umbilical cords of Gestational Diabetic mothers reveals candidate sites for an epigenetic modulation of specific gene expression. 77
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 77
I livelli di inibitore dell’attivatore del plasminogeno-1 (PAI-1) risultano aumentati nella parete arteriosa di pazienti diabetici 76
Arterial wall and liver of diabetic rats exhibit increased synthesis of plasminogen activator inhibitor-1 (PAI-1). 76
Blood sugar control in diabetic patients bearing microinfusors: the importance of the dawn phenomenon 76
Chronic in vivo hyperglycaemia increases nitroxidant stress and hinders nitric oxide availability in human vessels and human endothelial cells 76
The TRIB3 R84 variant is associated with increased carotid intima-media thickness in vivo and with enhanced MAPK signalling in human endothelial cells. 75
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 75
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 75
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 75
G972R IRS-1 variant impairs insulin regulation of eNOS in cultured human endothelial cells 74
The dawn phenomenon in Type I (insulin-dependent) diabetic patient treated by continuous subcutaneous insulin infusion. 74
Effects of a "single-meal" low calorie diet on the circadian variation of serum cortisol, insulin and somatotropin and urinary excretion of catecholamines. 74
Cigarette smoke, ferritin, and lipid peroxidation 74
Increased Plasminogen Activator Inhibitor (PAI-1) Synthesis and Gene Expression in Adipocyte of Diabetic Rats 73
Acute hyperglycemia and acute hyperinsulinemia both decrease plasma fibrinolytic activity and increase plasminogen activator type-1 (PAI-1) in the rat. 73
Assorbimento dell’insulina umana semisintetica dopo iniezione sottocutanea a spruzzo transcutaneo mediante iniettore 73
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 73
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 73
Features of endothelial dysfunction in umbilical cord vessels of women with gestational diabetes 73
Liraglutide mitigates TNF-alfa induced pro-atherogenic changes and microvesicle release in HUVEC from diabetic women 73
Inositol and antioxidant supplementation: Safety and efficacy in pregnancy 73
La dieta ipocalorica nella terapia del diabete di tipo 2 con obesità. Confronto con dieta ipo- e normoglicidica a differente contenuto calorico. 72
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance. 72
Ruolo del fegato 71
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 71
Plasminogen activator inhibitor type 1 is increased in the arterial wall of type 2 diabetic subjects 71
Valutazione dell’efficacia delle prestazioni nel servizio di diabetologia: impatto dell’emoglobina glicata 71
The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells. 71
Decreased expression of the plasminogen activator inhibitor-1 (PAI-1) gene in diabetic rats treated with phenylmethimazole 71
Semaglutide and cardiovascular outcomes in patients with type 2 diabetes 71
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 70
Iperespressione dell’inibitore dell’attivatore del plasminogeno di tipo 1 (PAI-1) nel fegato e nell’aorta di ratti diabetici 70
Soluble RAGE in type 2 diabetes: association with oxidative stress. 70
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 70
Il sintomo impotenza come esordio di una neuropatia diabetica nel paziente di sesso maschile 69
Combined effect of glucose and insulin in stimulating plasminogen activator inhibitor-1 secretion and gene expression in human vascular smooth muscle cells in culture 69
Can the glucose load test predict insulin requirement in gestational diabetes with normal fasting blood glucose (Type B)?. 69
Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study 69
Both acute and chronic hyperglycemia decrease plasma fribrinolytic activity in the rat. 68
Difetti Beta cellulari nel diabete di tipo 2 68
L’impatto socio-economico delle ipoglicemie 68
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 68
Deletion of Gly723 in the insulin receptor substrate-1 of a patient with noninsulin-dependent diabetes mellitus. 68
Interrelazione fra variazioni della glicoemoglobina e variazioni della massa corporea in diabetici di tipo 2 all’esordio seguiti per 6 anni. 67
Protective effects of glucagon-like peptide-1 on beta-cells: preclinical and clinical data. 67
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 67
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 67
Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture. 67
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 67
Short term vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects 66
Diabetes as risk factor for myocardial infarction and stroke in an italian population (Progetto 3A). 66
Potential side effects to GLP-1 agonists: Understanding their safety and tolerability 66
Cardiovascular biomarkers in clinical studies of type 2 diabetes 66
Totale 7.983
Categoria #
all - tutte 54.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019639 0 0 0 0 0 0 0 0 0 0 0 639
2019/20203.480 988 215 54 105 286 290 416 353 108 322 322 21
2020/20211.536 239 14 262 31 128 337 43 35 122 224 30 71
2021/20221.197 30 33 2 247 95 19 51 79 108 37 148 348
2022/20233.702 326 399 195 436 323 758 233 288 493 55 116 80
2023/20241.722 111 61 136 69 74 493 476 78 26 83 63 52
Totale 15.790